Section: 
Science articles
Science articlesThe treatment and efficacy of immunomodulator Bestim in the treatment of acute rhinosinusitis
A. S. Simbirtsev (1), Yu. K. Yanov (2), Z. S. Gulomov (3)
(1) Federal State Unitary Enterprise State Scientific Research Institute of High Purity Biological Preparations of the Federal Medico-Biological Agency of Russia, Saint Petersburg, Russia
(2) Federal State Budgetary Institution Saint Petersburg Research Institute of Ear, Throat, Nose and Speech of the Ministry of Healthcare of Russia, Saint Petersburg, Russia
(3) State Institution Avicenna Tajik State Medical University, Dushanbe, the Republic of Tajikistan
UDK: 616.211.1-08-039.73:615.37
DOI: https://doi.org/10.18692/1810-4800-2018-5-86-91
ABSTRACT
Acute rhinosinusitis is the most common disease, it accounts for 40 to 60% of morbidity in ENT-pathology structure. The article presents the treatment and efficacy of the preparation Bestim in comparison with the traditional therapy in the treatment of acute rhinosinusitis. Bestim is a dipeptide with immunostimulating effect. It stimulates cellular and humoral immunity, improves antibacterial and antiviral resistance.
Publication date:
01.10.2018
Keywords:
acute rhinosinusitis, preparation Bestim, therapy. For citation:
Simbirtsev A. S., Yanov Yu. K., Gulomov Z. S. The treatment and efficacy of immunomodulator Bestim in the treatment of acute rhinosinusitis. Rossiiskaya otorinolaringologiya. 2018;5:86–91. https://doi.org/10.18692/1810-4800-2018-5-86-91